| Cell line name |
FM37 |
| Accession |
CVCL_C584 |
| Resource Identification Initiative |
To cite this cell line use: FM37 (RRID:CVCL_C584) |
| Comments |
Derived from site: Metastatic; Not specified. |
| HLA typing |
Source: PubMed=7656272
| Class I | | HLA-A | A*02,03 | | HLA-B | B*07,40 | | HLA-C | C*03 |
|
| Disease |
Cutaneous melanoma (NCIt: C3510) |
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
| Sex of cell |
Sex unspecified |
| Age at sampling |
Age unspecified |
| Category |
Cancer cell line |
| Publications | PubMed=7656272; DOI=10.1007/BF01527402; PMCID=PMC11037630 Alexei F. Kirkin, Troels Reichert Petersen, Anna Catharina Olsen, Li Li, Per thor Straten, Jesper Zeuthen; Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines. Cancer Immunol. Immunother. 41:71-81(1995) PubMed=9288767 Per Guldberg, Per thor Straten, Anette Birck, Vibeke Ahrenkiel, Alexei F. Kirkin, Jesper Zeuthen; Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res. 57:3660-3663(1997) PubMed=11225993; DOI=10.1007/s002620000154; PMCID=PMC11036965 Luis M. Real, Pilar Jimenez, Alexei F. Kirkin, Alfonso Serrano, Aida Garcia, Julia Canton, Jesper Zeuthen, Federico Garrido, Francisco Ruiz-Cabello Osuna; Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient. Cancer Immunol. Immunother. 49:621-628(2001) |
| Cross-references |
| Encyclopedic resources |
Wikidata; Q54835030
|
| Entry history |
| Entry creation | 22-Oct-2012 |
| Last entry update | 29-Jun-2023 |
| Version number | 12 |
|---|